RE:volume speedy99 wrote: Low volume has been puzzling to me. Yesterday 554,794 shares traded. Lots of commentary on the board here about price action, but to me volume is key. Once we start getting significant volume the share price will move up quickly. To get the big volume we need the big buyers, the institutions. Although we have many analysts promoting the stock with some decent short term targets, that does not necessarily translate into institutional buying. As others have stated here, we perhaps need to build up a record of consistent performance and earnings. Ultimately that will be irresistable for the big funds. But the idea of a big institution looking at us and saying: "digitalization and modernization of health care, great idea, let's buy" - not happening. There are too many players in the field and there is a sense that demand will not continue after pandemic is under control. So what we need is a good history of significant earnings and stability. That will bring the institutions, which will bring the volume, which will drive the price up.
agreed speedy99.
this is why I think the NASDAQ listing is critical as US institutional investors are
far more comfortable paying for future earnings potential / future growth potential. look at the stock valuations of some big telehealth players there who aren't even cashflow positive, or profitable. many Canadian institutional investors are conservative and take the wait-and-see approach with companies like WELL, who need to prove out their earnings. WELL only just graduated to the TSX in the last year, only just became part of the Composite Index recently, and really only became an institutionally sized company when they bought CRH (and just barely). many institutional funds can't even invest in companies this small.
with a few quarters of proven growth/results, and maybe some more M&A, this stock will absolutely take off. there is no doubt in my mind.